Opportunities for nanotheranosis in lung cancer and pulmonary metastasis

Jaehong Key, Y. S. Kim, F. Tatulli, A. L. Palange, B. O’Neill, S. Aryal, M. Ramirez, X. Liu, M. Ferrari, R. Munden, P. Decuzzi

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Malignancies of the lungs, both primary and metastatic, are the leading cause of death worldwide. Over 1.5 million new cases of primary lung cancer are diagnosed annually worldwide with a dismal 5-year survival rate of approximately 15 %, which remains unchanged despite major efforts and medical advances. As expected, survival for patients with lung metastases is even worse at about 5 %. Early detection and staging are fundamental in improving survival rates and selecting the most effective treatment strategies. Recently, nanoparticles have been developed for imaging and treating various cancers, including pulmonary malignancies. In this work, three different examples of nanoparticle configurations for cancer theranosis are presented, namely conventional spherical polymeric nanoparticles with a diameter of ~150 nm; and discoidal mesoporous silicon nanoconstructs and discoidal polymeric nanoconstructs with a diameter of ~1,000 nm and a height of 400 and 500 nm, respectively. The spherical nanoparticles accumulate in tumors by means of the well-known enhanced permeation and retention effect, whereas sub-micrometer discoidal nanoconstructs are rationally designed to adhere firmly to the tortuous tumor vasculature. All three nanoparticles are characterized for their in vivo performance in terms of magnetic resonance, positron-emission tomography (PET), and optical imaging. Preliminary data on the in vivo and ex vivo PET/CT imaging of breast cancer metastasis in the lungs using discoidal nanoconstructs is presented. In conclusion, opportunities for nanoparticle-based theranosis in primary lung cancer and pulmonary metastasis are presented and discussed.

Original languageEnglish
Pages (from-to)427-437
Number of pages11
JournalClinical and Translational Imaging
Volume2
Issue number5
DOIs
Publication statusPublished - 2014 Oct 25

Fingerprint

Nanoparticles
Lung Neoplasms
Neoplasm Metastasis
Lung
Neoplasms
Positron-Emission Tomography
Survival Rate
Optical Imaging
Silicon
Cause of Death
Magnetic Resonance Spectroscopy
Breast Neoplasms
Survival

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Key, J., Kim, Y. S., Tatulli, F., Palange, A. L., O’Neill, B., Aryal, S., ... Decuzzi, P. (2014). Opportunities for nanotheranosis in lung cancer and pulmonary metastasis. Clinical and Translational Imaging, 2(5), 427-437. https://doi.org/10.1007/s40336-014-0078-7
Key, Jaehong ; Kim, Y. S. ; Tatulli, F. ; Palange, A. L. ; O’Neill, B. ; Aryal, S. ; Ramirez, M. ; Liu, X. ; Ferrari, M. ; Munden, R. ; Decuzzi, P. / Opportunities for nanotheranosis in lung cancer and pulmonary metastasis. In: Clinical and Translational Imaging. 2014 ; Vol. 2, No. 5. pp. 427-437.
@article{f7efa5da226d4f5fbc4d6122262597b0,
title = "Opportunities for nanotheranosis in lung cancer and pulmonary metastasis",
abstract = "Malignancies of the lungs, both primary and metastatic, are the leading cause of death worldwide. Over 1.5 million new cases of primary lung cancer are diagnosed annually worldwide with a dismal 5-year survival rate of approximately 15 {\%}, which remains unchanged despite major efforts and medical advances. As expected, survival for patients with lung metastases is even worse at about 5 {\%}. Early detection and staging are fundamental in improving survival rates and selecting the most effective treatment strategies. Recently, nanoparticles have been developed for imaging and treating various cancers, including pulmonary malignancies. In this work, three different examples of nanoparticle configurations for cancer theranosis are presented, namely conventional spherical polymeric nanoparticles with a diameter of ~150 nm; and discoidal mesoporous silicon nanoconstructs and discoidal polymeric nanoconstructs with a diameter of ~1,000 nm and a height of 400 and 500 nm, respectively. The spherical nanoparticles accumulate in tumors by means of the well-known enhanced permeation and retention effect, whereas sub-micrometer discoidal nanoconstructs are rationally designed to adhere firmly to the tortuous tumor vasculature. All three nanoparticles are characterized for their in vivo performance in terms of magnetic resonance, positron-emission tomography (PET), and optical imaging. Preliminary data on the in vivo and ex vivo PET/CT imaging of breast cancer metastasis in the lungs using discoidal nanoconstructs is presented. In conclusion, opportunities for nanoparticle-based theranosis in primary lung cancer and pulmonary metastasis are presented and discussed.",
author = "Jaehong Key and Kim, {Y. S.} and F. Tatulli and Palange, {A. L.} and B. O’Neill and S. Aryal and M. Ramirez and X. Liu and M. Ferrari and R. Munden and P. Decuzzi",
year = "2014",
month = "10",
day = "25",
doi = "10.1007/s40336-014-0078-7",
language = "English",
volume = "2",
pages = "427--437",
journal = "Clinical and Translational Imaging",
issn = "2281-5872",
publisher = "Springer-Verlag Italia",
number = "5",

}

Key, J, Kim, YS, Tatulli, F, Palange, AL, O’Neill, B, Aryal, S, Ramirez, M, Liu, X, Ferrari, M, Munden, R & Decuzzi, P 2014, 'Opportunities for nanotheranosis in lung cancer and pulmonary metastasis', Clinical and Translational Imaging, vol. 2, no. 5, pp. 427-437. https://doi.org/10.1007/s40336-014-0078-7

Opportunities for nanotheranosis in lung cancer and pulmonary metastasis. / Key, Jaehong; Kim, Y. S.; Tatulli, F.; Palange, A. L.; O’Neill, B.; Aryal, S.; Ramirez, M.; Liu, X.; Ferrari, M.; Munden, R.; Decuzzi, P.

In: Clinical and Translational Imaging, Vol. 2, No. 5, 25.10.2014, p. 427-437.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Opportunities for nanotheranosis in lung cancer and pulmonary metastasis

AU - Key, Jaehong

AU - Kim, Y. S.

AU - Tatulli, F.

AU - Palange, A. L.

AU - O’Neill, B.

AU - Aryal, S.

AU - Ramirez, M.

AU - Liu, X.

AU - Ferrari, M.

AU - Munden, R.

AU - Decuzzi, P.

PY - 2014/10/25

Y1 - 2014/10/25

N2 - Malignancies of the lungs, both primary and metastatic, are the leading cause of death worldwide. Over 1.5 million new cases of primary lung cancer are diagnosed annually worldwide with a dismal 5-year survival rate of approximately 15 %, which remains unchanged despite major efforts and medical advances. As expected, survival for patients with lung metastases is even worse at about 5 %. Early detection and staging are fundamental in improving survival rates and selecting the most effective treatment strategies. Recently, nanoparticles have been developed for imaging and treating various cancers, including pulmonary malignancies. In this work, three different examples of nanoparticle configurations for cancer theranosis are presented, namely conventional spherical polymeric nanoparticles with a diameter of ~150 nm; and discoidal mesoporous silicon nanoconstructs and discoidal polymeric nanoconstructs with a diameter of ~1,000 nm and a height of 400 and 500 nm, respectively. The spherical nanoparticles accumulate in tumors by means of the well-known enhanced permeation and retention effect, whereas sub-micrometer discoidal nanoconstructs are rationally designed to adhere firmly to the tortuous tumor vasculature. All three nanoparticles are characterized for their in vivo performance in terms of magnetic resonance, positron-emission tomography (PET), and optical imaging. Preliminary data on the in vivo and ex vivo PET/CT imaging of breast cancer metastasis in the lungs using discoidal nanoconstructs is presented. In conclusion, opportunities for nanoparticle-based theranosis in primary lung cancer and pulmonary metastasis are presented and discussed.

AB - Malignancies of the lungs, both primary and metastatic, are the leading cause of death worldwide. Over 1.5 million new cases of primary lung cancer are diagnosed annually worldwide with a dismal 5-year survival rate of approximately 15 %, which remains unchanged despite major efforts and medical advances. As expected, survival for patients with lung metastases is even worse at about 5 %. Early detection and staging are fundamental in improving survival rates and selecting the most effective treatment strategies. Recently, nanoparticles have been developed for imaging and treating various cancers, including pulmonary malignancies. In this work, three different examples of nanoparticle configurations for cancer theranosis are presented, namely conventional spherical polymeric nanoparticles with a diameter of ~150 nm; and discoidal mesoporous silicon nanoconstructs and discoidal polymeric nanoconstructs with a diameter of ~1,000 nm and a height of 400 and 500 nm, respectively. The spherical nanoparticles accumulate in tumors by means of the well-known enhanced permeation and retention effect, whereas sub-micrometer discoidal nanoconstructs are rationally designed to adhere firmly to the tortuous tumor vasculature. All three nanoparticles are characterized for their in vivo performance in terms of magnetic resonance, positron-emission tomography (PET), and optical imaging. Preliminary data on the in vivo and ex vivo PET/CT imaging of breast cancer metastasis in the lungs using discoidal nanoconstructs is presented. In conclusion, opportunities for nanoparticle-based theranosis in primary lung cancer and pulmonary metastasis are presented and discussed.

UR - http://www.scopus.com/inward/record.url?scp=84940638897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940638897&partnerID=8YFLogxK

U2 - 10.1007/s40336-014-0078-7

DO - 10.1007/s40336-014-0078-7

M3 - Review article

VL - 2

SP - 427

EP - 437

JO - Clinical and Translational Imaging

JF - Clinical and Translational Imaging

SN - 2281-5872

IS - 5

ER -